article · SVU-International Journal of Medical Sciences
Background: Although several studies were conducted on treatment of localized vitiligo with multiple adjuvants, there is no ideal therapy with optimum results.Objectives: The purpose of this research is to compare the effectiveness of topical 5-fluorouracil and topical latanoprost in stimulating skin regimentation in patients with localized stable vitiligo following skin microneedling.Patients and methods: This prospective randomized clinical trial conducted on forty patients with localized stable vitiligo was divided randomly into two groups: Group (A): 20 patients were received latanoprost after microneedling Group (B): 20 patients were received 5-Flourouracil 5% solution after microneedling. All patients were clinically and photographically evaluated using Vitiligo Area Scoring Index (VASI).Results: There was no statistically significant difference between both groups regarding the degree of repigmentation in response to treatment (p value = 0.317). Excellent improvement (> 75% repigmentation) was achieved in 45% of patients in both groups. Also, there was significant reduction in the VASI score for both groups when comparing post-treatment with the baseline. As regard the complications, there was minimal complications only one case with post inflammatory hyperpigmentation.Conclusion: Microneedling combined with 5-Fluorouracil or latanoprost are both safe and effective treatments of localized stable vitiligo with no significant difference.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/svuijm.2024.252488.1749
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.